<--- Back to Details
First PageDocument Content
Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Stimulants / Phenethylamines / Attention deficit hyperactivity disorder management / Off-label use / Atomoxetine / Adult attention deficit hyperactivity disorder / Placebo / Pemoline / Lisdexamfetamine
Date: 2015-12-21 11:29:00
Amphetamine
Methylphenidate
Attention deficit hyperactivity disorder
Stimulants
Phenethylamines
Attention deficit hyperactivity disorder management
Off-label use
Atomoxetine
Adult attention deficit hyperactivity disorder
Placebo
Pemoline
Lisdexamfetamine

prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

Add to Reading List

Source URL: odprn.ca

Download Document from Source Website

File Size: 1,15 MB

Share Document on Facebook

Similar Documents

Listing By Classification

Listing By Classification

DocID: 1qDsa - View Document

prilTreatments for Attention Deficit Hyperactivity Disorder in Adults  FINAL PHARMACOEPIDEMIOLOGY REPORT

prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT

DocID: 1pBj0 - View Document

NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants  The NCAA bans classes of drug

NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants The NCAA bans classes of drug

DocID: 1pvtZ - View Document

NCAA Guidelines to Document ADHD Treatment with Banned Stimulant Medications Addendum to the January 2009 Guidelines Q & A MarchWhy is the NCAA instituting a stricter application of the medical exception policy

NCAA Guidelines to Document ADHD Treatment with Banned Stimulant Medications Addendum to the January 2009 Guidelines Q & A MarchWhy is the NCAA instituting a stricter application of the medical exception policy

DocID: 1oviK - View Document

prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

DocID: 1ou1z - View Document